Key Points
            - Use the highest‑yield diagnostic test early; do not let testing delay time‑critical therapy.
- Set objective targets and reassess frequently.
- Plan definitive source control or disease‑specific therapy when indicated; document follow‑up and patient education.
                                        Algorithm
            - Suspect epiglottitis → minimize agitation; prepare controlled airway.
- Start broad IV antibiotics; obtain imaging/endoscopy only when safe.
- Monitor closely; de-escalate therapy based on cultures; vaccinate contacts if indicated.
                                        Clinical Synopsis & Reasoning
            Abrupt sore throat, dysphagia, muffled voice, and drooling with normal oropharyngeal exam suggests epiglottitis. Avoid agitating the airway; secure in a controlled setting if signs of obstruction. Start IV ceftriaxone + vancomycin (coverage varies) and obtain lateral neck radiograph or fiberoptic exam when safe.
                                        Treatment Strategy & Disposition
            Stabilize ABCs. Initiate guideline‑concordant first‑line therapy with precise dosing and continuous monitoring. Escalate to advanced/procedural interventions based on explicit failure criteria. Define ICU, step‑down, and ward disposition triggers; involve specialty teams early.
                                        Epidemiology / Risk Factors
            - Risk varies by comorbidity and precipitants; see citations for condition‑specific data.
                                        Investigations
            
              
                | Test | Role / Rationale | Typical Findings | Notes | 
|---|
                
                  | Bedside assessment for stridor, tripod posture, drooling | Airway risk | Clinical diagnosis | Avoid tongue depressor in distress | 
| Lateral neck radiograph or nasopharyngoscopy (when safe) | Diagnosis | Thumb sign, swollen epiglottis | Only after airway plan | 
| Blood cultures and inflammatory markers | Etiology | H. influenzae, staph, strep | Tailor therapy | 
                
              
             
                                        High-Risk & Disposition Triggers
            
              
                | Trigger | Why it matters | Action | 
|---|
                
                  | Stridor, tripod posture, drooling | Impending airway closure | Airway in OR setting; ENT/anesthesia | 
| Rapid progression in adults with diabetes | Severe course | Early broad-spectrum antibiotics | 
| Abscess or failure of antibiotics | Complication | Surgical drainage | 
| Immunosuppression | Atypical pathogens | Tailor therapy | 
| Limited resources for airway rescue | Safety | Transfer to facility with airway expertise | 
                
              
             
                                        Pharmacology
            
              
                | Medication/Intervention | Mechanism | Onset | Role in Therapy | Limitations | 
|---|
                
                  | Airway control in OR with ENT/anesthesia | Definitive | Immediate | Prevent sudden obstruction | — | 
| Ceftriaxone 2 g IV daily + Vancomycin | Empiric antibiotics | Hours | Cover common pathogens | Adjust to cultures | 
| Dexamethasone (selected) | Adjunct | Hours | Reduce edema (controversial) | — | 
                
              
             
                                        Prognosis / Complications
            - Outcome depends on timeliness of diagnosis and definitive therapy; monitor for complications.
                                        Patient Education / Counseling
            - Provide red‑flag education, adherence guidance, and explicit return precautions; arrange timely specialty follow‑up.
                  
        
                  References
                      - ENT/infectious disease guidance on adult epiglottitis — Link